Cholera Vaccines
Oral killed and live-attenuated vaccines
This page catalogs 3 cholera vaccine products. Modern cholera vaccines are all oral formulations, reflecting the enteric nature of the disease. Cholera vaccination is primarily recommended for travelers to endemic areas and populations in outbreak settings.
Last updated: April 2026.
Cholera Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| Dukoral | Oral killed whole-cell + recombinant B-subunit (WC-rBS) | Valneva | Killed whole-cell oral | WHO Prequalified | Also provides short-term ETEC protection |
| Vaxchora | Oral cholera vaccine, live-attenuated CVD 103-HgR | Emergent BioSolutions (PaxVax) | Live-attenuated oral | FDA Licensed, 2016 | Only US-licensed cholera vaccine |
| Shanchol | Oral killed whole-cell bivalent cholera vaccine | Sanofi (Shantha) | Killed whole-cell oral | WHO Prequalified | Endemic/epidemic use |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026) and WHO Prequalified Vaccines list. Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.